Tag: Catalent
Catalent, deal with activist investor Elliot. Go to strategic review
(Tiper Stock Exchange) – Catalenta US company specializing in pharmaceutical outsourcing services, has added four new members to its board of directors and announced it will lead a strategic review…
Catalent cuts guidance and receives delisting notice from NYSE
(Tiper Stock Exchange) – Catalenta US company active in the production and packaging of pharmaceutical products, has lowered its guidance for fiscal 2023 to reflect expected third-quarter results (including pandemic-related…